EB
Strainsforpains, Inc.
EBYH · OTC
$0.20 +0.00% (+$0.00)
1M -8.05%
Market Cap $2.09M
P/E Ratio -
Div. Yield -
ROE 3.16%
Bulios Fair Price
$0.25
25.0% upside
Current Price
$0.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EBYH is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive EV/EBITDA 47.70x
P/S 11.60x
P/E N/A
Growth
100 /100
Growing Rev. growth 170.50%
EPS growth N/A
Book val. growth N/A
Profitability
30 /100
Weak Gross margin 0.00%
FCF margin 106.41%
Net margin 17.63%
Quality
15 /100
Poor ROIC 4.98%
Asset turnover 0.10x
ROE 3.16%
Debt
24 /100
High Current ratio 7.67x
Net debt/EBITDA 23.05x
Int. coverage 0.73x
Stability
30 /100
Unstable Beta -0.23x
Profitable years 0
Rev. volatility 575.56%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EBYH
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Yeshua Simon Shainberg
Employees
0
Headquarters
New York City